Home Cart Sign in  
Chemical Structure| 1644342-14-2 Chemical Structure| 1644342-14-2

Structure of ML-792
CAS No.: 1644342-14-2

Chemical Structure| 1644342-14-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ML-792 is a potent and selective inhibitor of SAE/SUMO1 and SAE/SUMO2 in enzymatic assays, with IC50 values of 3 nM and 11 nM, respectively. It is much less effective against NAE/NEDD8 and UAE/ubiquitin, with IC50 values exceeding 32 μM and 100 μM, respectively.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ML-792

CAS No. :1644342-14-2
Formula : C21H23BrN6O5S
M.W : 551.41
SMILES Code : O=S(OC[C@@H]1[C@@H](O)C[C@H](NC2=NC=NC=C2C(C3=NN(CC4=CC=CC(Br)=C4)C=C3)=O)C1)(N)=O
MDL No. :MFCD32174257
InChI Key :PZCKLTWSXFDLLP-OGWOLHLISA-N
Pubchem ID :86566743

Safety of ML-792

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HL-60 cells 0.5 µM 2 hours To assess the impact of deSUMOylation on gene expression related to DNR treatment. Nucleic Acids Res. 2023 Sep 8;51(16):8413-8433.
HCT116 cells 200 µM 24 hours The results show enhanced sensitivity to apoptosis in response to the treatments. Signal Transduct Target Ther. 2020 Jun 24;5(1):80.
Raw264.7 macrophages 0.5 µM 24 hours ML-792 inhibits SUMOylation, increasing S. aureus replication within macrophages. Int J Mol Sci. 2021 Jul 28;22(15):8108.
VCaP cells 1 µM 24 hours Inhibition of SUMOylation to observe its effects on AR chromatin interactions and gene expression. Results showed that SUMOi enhanced AR binding on inaccessible chromatin regions and reduced its interaction with accessible chromatin regions. Nucleic Acids Res. 2024 Sep 9;52(16):9519-9535.
LNCaP cells 1 µM 24 hours Inhibition of SUMOylation to observe its effects on cell proliferation. Results showed that SUMOi inhibited cell proliferation both in the presence and absence of androgen. Nucleic Acids Res. 2024 Sep 9;52(16):9519-9535.
HCT-8/5-FU 0.1 µM 48 hours Inhibits SUMOylation to enhance sensitivity to 5-FU. Front Pharmacol. 2024 Jul 23;15:1381860.
EBV-positive B cell lines 0.001 µM, 0.01 µM, 0.1 µM, 1 µM, and 10 µM 96 hours ML-792 inhibited sumoylation processes in EBV-positive B cell lines and inhibited B-cell growth, promoting cell death. Antiviral Res. 2021 Apr;188:105038.
EBV-positive nasopharyngeal carcinoma cell lines 0.001 µM, 0.01 µM, 0.1 µM, 1 µM, and 10 µM 96 hours ML-792 inhibited sumoylation processes in EBV-positive nasopharyngeal carcinoma cell lines. Antiviral Res. 2021 Apr;188:105038.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/C nude mice Xenograft tumor model Intraperitoneal injection 200 µM Every 2 days for 10 days The study aimed to evaluate the effects of 2-D08 on tumor growth, showing potential for enhancing sensitivity to DNA-damaging agents in a therapeutic context. Signal Transduct Target Ther. 2020 Jun 24;5(1):80.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.81mL

0.36mL

0.18mL

9.07mL

1.81mL

0.91mL

18.14mL

3.63mL

1.81mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories